Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients | Zendy

Sergio Vergara | Zendy; Juan Macı́as | Zendy; J. A. Mira | Zendy; José Ángel García-García | Zendy; Nicolás Merchante | Zendy; José del Valle | Zendy; Laila AbdelKader Martín | Zendy; Fernando Lozano | Zendy; Jesús GómezMateos | Zendy; Juan A. Pineda | Zendy

Open Access

Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients

Author(s) -

Sergio Vergara,

Juan Macı́as,

J. A. Mira,

José Ángel García-García,

Nicolás Merchante,

José del Valle,

Laila AbdelKader Martín,

Fernando Lozano,

Jesús GómezMateos,

Juan A. Pineda

Publication year - 2006

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkl447

Subject(s) - medicine , gastroenterology , liver biopsy , fibrosis , lees , liver disease , population , hepatitis c virus , biopsy , immunology , virus , biology , food science , environmental health , fermentation

To assess the association between non-severe liver enzyme elevations (LEEs) during antiretroviral treatment and liver fibrosis in HIV/HCV-coinfected patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research